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ecent studies have shown that the transport of mi-
crotubules (MTs) and neuroﬁlaments (NFs) within
the axon is rapid, infrequent, asynchronous, and
bidirectional. Here, we used RNA interference to investi-
gate the role of cytoplasmic dynein in powering these
transport events. To reveal transport of MTs and NFs, we
expressed EGFP-tagged tubulin or NF proteins in cultured
rat sympathetic neurons and performed live-cell imaging
R
 
of the ﬂuorescent cytoskeletal elements in photobleached
regions of the axon. The occurrence of anterograde MT
and retrograde NF movements was signiﬁcantly dimin-
ished in neurons that had been depleted of dynein heavy
chain, whereas the occurrence of retrograde MT and
anterograde NF movements was unaffected. These results
support a cargo model for NF transport and a sliding
ﬁlament model for MT transport.
 
Introduction
 
Early studies on slow axonal transport suggested that the proteins
that comprise microtubules (MTs), actin filaments, and neurofila-
ments (NFs) are transported in the form of assembled polymers
(Black and Lasek, 1980). Photobleach studies performed in the
1990s failed to reveal coherent movement of the polymers, leading
to the theory that the polymers are stationary, whereas the
proteins move in an unassembled form (Lim et al., 1990). Using
longer bleached zones and natural gaps in the NF array, it has
been observed in more recent studies that MTs and NFs are
indeed in motion, but move rapidly, asynchronously, bi-direc-
tionally, and intermittently (Wang et al., 2000; Roy et al., 2000;
Wang and Brown, 2001, 2002). These observations suggest that
slow axonal transport is a collection of fast but infrequent move-
ments, which appear slow when the population of moving and
nonmoving polymers are studied collectively. Cytoplasmic
dynein is a good candidate as a motor for slow axonal transport
because it generates a variety of cytoskeletal movements in other
cell types (Abal et al., 2002; Dujardin et al., 2003).
Cytoplasmic dynein moves toward minus ends of MTs,
and thereby transports vesicular organelles in the retrograde
direction in the axon. In a “cargo” model for slow axonal
transport, cytoplasmic dynein would also convey short MTs and
NFs retrogradely by moving them along longer MTs. If this is
correct, then the anterograde movements are presumably gener-
ated by members of the kinesin superfamily. Alternatively, in a
“sliding filament” model, cytoplasmic dynein could fuel antero-
grade transport of short MTs if the cargo domain of dynein inter-
faces with a structure with more resistance to movement than the
short MT (Ahmad et al., 1998). In the classic radiolabel para-
digm for slow axonal transport, cytoplasmic dynein tends to
move at the somewhat faster rate of actin filaments rather than
the somewhat slower rate of MTs and NFs (Dillman et al.,
1996). On this basis, it was proposed that the cargo-binding
domain of the motor interfaces with the actin cytoskeleton,
leaving the motor domain available to translocate MTs. It is also
possible that bidirectional MT movements occur along other
MTs, with the directionality depending on the configuration of
the motor between the moving and nonmoving MT. Such move-
ments could be fueled entirely by cytoplasmic dynein or might
involve other motors as well. The sliding filament model might
also account for NF transport, if the NFs simply “piggy back” on
MTs through nonmotor cross-links, and move as the MT moves
(Brady, 2000).
Understanding the specific roles of cytoplasmic dynein in
MT and NF transport is key to distinguishing between the
cargo model and the sliding filament model for each cytoskeletal
element, and hence for elucidating the mechanisms that orches-
trate slow axonal transport.
 
Results and discussion
 
Diminution of dynein heavy chain (DHC) in 
cultured sympathetic neurons by siRNA
 
We used a mixture of four different siRNA duplexes that target
different regions on the mRNA of DHC. Quantitative immuno-
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fluorescence images revealed that more than 80% of neurons in
DHC siRNA-treated cultures exhibit a dramatic diminution of
the protein (Fig. 1, A and B). Significant protein reduction starts
as early as 2 d and proceeds at least until 6 d after siRNA trans-
fection when 
 
 
 
20% of the protein is still present (Fig. 1 C).
Western blot analyses confirmed the drastic depletion of DHC
by siRNA (Fig. 1 D). Furthermore, when stripped and reprobed
with a MAP1b antibody, the DHC bands migrated just ahead of
the MAP1b bands, as expected (Bloom et al., 1984), and we de-
tected no diminution in the levels of MAP1b as a result of the
DHC siRNA (Fig. 1, E and F). Therefore, assuming that the
DHC antibody recognizes most or all isoforms of the DHC pro-
tein, we are able to specifically knock down at least 80% and
perhaps over 90% of the protein in sympathetic neurons.
In a previous paper, we reported that acute disruption of
dynactin by microinjection of recombinant dynamitin impairs
both axonal growth and MT transport from the neuronal cen-
trosome (Ahmad et al., 1998). We used the siRNA approach for
the present work because dynactin disruption is now known to
have effects in addition to dynein inhibition (Schroer, 2004). Un-
like acute dynactin disruption, the gradual depletion of DHC by
siRNA did not markedly impair the formation and growth of ax-
ons. These differing results may relate to the broader effects of
dynactin disruption and/or to the longer period of time required
for the cessation of dynein function with the siRNA approach.
 
Golgi disruption and interruption of 
vesicle traffic by DHC depletion
 
Golgi dispersion is a reliable indicator of dynein inhibition. In
control siRNA-treated neurons, the Golgi apparatus appears as
a compact, multi-tubule structure located near the cell center
(Fig. 2 A). In DHC-depleted neurons, the Golgi apparatus be-
came elongated, less compact, and distributed throughout the
cell body after 4 d of siRNA treatment (Fig. 2 B). Quantifica-
tion of Golgi size revealed that the dispersion became signifi-
cant from 4 d and progressed until 6 d after siRNA transfection
(Fig. 2 C). We also examined vesicle transport behaviors in liv-
ing sympathetic neurons treated with control or DHC siRNA.
Neurons were incubated with rhodamine-dextran to label a
subfraction of vesicular structures arising from endocytosis
(Hollenbeck, 1993). The moving behaviors of fluorescent vesi-
cles were recorded by time-lapse imaging and analyzed for
both the frequency and the persistence of their movements
within the axon. We found that by 2 d after transfection, the
number of anterogradely and retrogradely moving vesicles per
axon per minute was not affected by DHC siRNA treatment
(
 
t
 
-test; Fig. 2 E and Table S1, available at http://www.jcb.org/
cgi/content/full/jcb.200407191/DC1). In addition, the percent-
age of vesicles that exhibit processive or sustained motion (for
definition see Materials and methods; Fig. 2 D) was not affected
in either direction at 2 d of DHC siRNA treatment (
 
t
 
-test; Fig. 2
E and Table S1). However, by 4 d after DHC siRNA transfec-
tion, the frequencies of vesicle movements were significantly
diminished in both anterograde and retrograde directions, and
to similar extent (Fig. 2 E and Table S1). The percentage of
sustained movements was decreased, but not significantly, in
the anterograde direction (13% decrease; P 
 
  
 
0.07). However,
the percentage of labeled vesicles exhibiting sustained retro-
grade movements was significantly decreased by DHC deple-
tion (43% decrease; P 
 
  
 
0.01; Fig. 2 E and Table S1).
Figure 1. Depletion of DHC by siRNA. Immunofluorescence indicates depletion of DHC in DHC siRNA-treated sympathetic neurons (B), compared with
control siRNA-treated neurons (A). (C) Quantification of total fluorescent intensity within soma revealed the progression of DHC depletion by siRNA (t-test,
*, P   0.05). Western blots of whole cell extracts probed with the DHC antibody (D) confirmed the protein lowering effect. The blot was stripped and reprobed
with a MAP1b antibody (E), and the overlay (F) confirmed the specificity of both the DHC antibody and the DHC depletion by siRNA. Arrowheads in D–F
indicate the 219-kD molecular mass marker. Bar, 20  m. 
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In summary, by 2 d after DHC siRNA transfection, when
 
 
 
35% of the heavy chain is still present, no indication of com-
promised dynein function is detected by either Golgi distribu-
tion or vesicle transport behavior. By 4 d, when the protein
level is further diminished to 
 
 
 
20% of control, predictable ef-
fects of dynein suppression are apparent. The effects on vesicle
transport (although showing some bias in the retrograde direc-
tion with regard to the sustained movements) are apparent in
both the anterograde and retrograde directions, which is consis-
tent with previous studies indicating that inhibition of either ki-
nesin or cytoplasmic dynein affects both directions of transport
(Martin et al., 1999; Gross et al., 2002). The reason for such
bidirectional inhibition is unclear, but possibly relates to the
mechanisms by which various motors coordinate with one an-
other. The fact that no noticeable changes were apparent at 2 d
suggests that 3–4 d is the earliest time point at which dynein
levels are sufficiently reduced to reliably produce predictable
and specific dynein deficits. Studies on NF transport at 2 d also
failed to reveal any deficits (Table S2, available at http://
www.jcb.org/cgi/content/full/jcb.200407191/DC1), and hence
we focused on 3–4 d as our earliest time point for detailed anal-
yses on deficits in NF and MT transport.
 
Effects of inhibition of cytoplasmic 
dynein on NF polymer distribution and 
transport in the axon
 
Cytoplasmic dynein has been shown to interact with NF pro-
teins (Wagner et al., 2004) and to move NFs in relation to MTs
in vitro (Shah et al., 2000). To investigate effects of dynein de-
pletion on NF transport in axons, we performed the NF trans-
port assay as previously described (Roy et al., 2000; Francis et
al., 2005) on neurons exposed to DHC siRNA. The distribution
of EGFP-NFH revealed a distal accumulation of NFs in DHC
siRNA-treated neurons (Fig. 3, A–D) from day 4 (but not day
2). In controls, we observed fast moving NFs in natural gaps or
in photobleached regions in axons, similar to that reported pre-
viously (Roy et al., 2000; Wang et al., 2000; Fig. 3 E). These
movements occur in both anterograde and retrograde direc-
tions, with a frequency ratio of roughly 1:1 (see Table S2 for
details). However, in neurons treated with DHC siRNA for 5 to
Figure 2. DHC depletion results in Golgi dispersion and partial vesicle transport inhibition. Golgi-58K protein immunostaining revealed compact Golgi
apparatus in a control siRNA-treated neuron (A) and dispersed Golgi apparatus in a DHC siRNA-treated neuron (B) 6 d after siRNA transfection.
(C) Quantification of Golgi area relative to soma area revealed a gradual increase of the Golgi size in DHC siRNA-treated neurons (t-test, *, P   0.05)
starting from 4 d after siRNA transfection. Bar, 10  m. (D) Left panel shows an anterogradely moving vesicle (arrowhead) with elapsed time in seconds.
Distance traversed is depicted by closed circles in graph. Right panel shows a retrogradely transported vesicle (arrowhead), with movement depicted by
red squares in the graph. Graph shows cumulative distance plots of four vesicles that underwent transport during 60 s (4 d DHC siRNA). Each plot shows
the position of the moving vesicle in successive frames relative to the starting position. Black and red plots depict anterogradely and retrogradely moving
vesicles, respectively. Both anterogradely transported vesicles and one of the retrogradely moving vesicles (red squares) undergo relatively sustained
movement, whereas the other retrogradely moving vesicle spends more time paused than moving. (E) Summary of results of DHC depletion on vesicle
transport frequencies and processivity (t-test, *, P   0.05). See Results and discussion and Table S1 for details. 
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8 d, the frequency of retrograde movements was dramatically
decreased, whereas that of anterograde movements increased
(Table S2), resulting in a large increase of the anterograde to
retrograde movement ratio (
 
 
 
24:1; Fig. 3 F).
The specific inhibition of retrograde transport, which is
dissimilar to the effects on MTs (see the following section), is
consistent with the cargo model, but inconsistent with the idea
of NFs piggy backing on moving MTs. The cargo model also
fits well with the results of studies on the transport of interme-
diate filaments by molecular motors in other systems (Helfand
et al., 2002; Xia et al., 2003).
 
Effects of inhibition of cytoplasmic dynein 
on MT polymer transport in the axon
 
To assay MT transport, we used the photobleach method of
Wang and Brown (2002), except that we expressed EGFP-
tubulin rather than injecting rhodamine-tubulin. We analyzed
MT transport behaviors after 4 d of siRNA transfection, by
which time the decrease of DHC level had significantly inhib-
ited dynein function, as revealed by Golgi distribution, vesicle
transport, and NF transport. In neurons cotransfected with con-
trol siRNA, the majority of moving MTs was transported in the
anterograde direction, with an anterograde to retrograde fre-
quency ratio of 
 
 
 
2:1 (see Table S3 for details, available at
http://www.jcb.org/cgi/content/full/jcb.200407191/DC1). In
DHC siRNA-treated neurons, the frequency of anterograde MT
movements is diminished (
 
x
 
2
 
, P 
 
  
 
0.05), whereas that in the
retrograde direction remains unchanged, resulting in a drop of
anterograde to retrograde movement ratio to 1:1 (Table S3). At
day 7, a similar decrease is observed in the anterograde fre-
quency, as well as the anterograde to retrograde ratio of MT
movements. There is a small diminution in the frequency of
retrograde transport of MTs at day 7, but this did not achieve
statistical significance (Fig. 4 B). Combining the data from
days 4 and 7, the frequency of anterograde MT movements is
significantly diminished upon dynein inhibition by RNAi (
 
x
 
2
 
,
P 
 
  
 
0.05), but the frequency of retrograde MT movements is
not significantly affected. Comparing populations of control and
DHC-depleted axons, there was no significant difference be-
tween the instantaneous velocities (Fig. 4, F and G), but there
was a small but statistically significant decrease in the average
velocities of both anterograde (2-tailed 
 
t
 
-test, P 
 
  
 
0.0001) and
retrograde movements (2-tailed 
 
t
 
-test, P 
 
  
 
0.05; Fig. 4, D and E)
in DHC siRNA-treated axons due to a prolongation of the pe-
riod of time MTs spend in pausing (Table S3).
These results demonstrate that cytoplasmic dynein is a ma-
jor participant in the anterograde transport of MTs, therefore sup-
porting the sliding filament model for axonal MT transport. We
cannot conclude whether or not cytoplasmic dynein is the only
motor that fuels the anterograde movements because the neurons
Figure 3. Retrograde NF transport is suppressed in
DHC-depleted neurons. A–D show GFP-NFH fluores-
cence in living neurons treated with control siRNA (A)
or DHC siRNA for 4 d (B) or 6 d (C and D). The insets
in C and D show the accumulation and disorganization
of NFs in the axonal tip at higher magnification. Bars:
(A–E) 8  m; (insets) 25  m. (E) Selected frames from
a sequence showing anterograde (upper left-to-lower
right) translocation of two NFs. Time in seconds is in-
dicated above each frame. The bracket in the 0 s
frame identifies a gap in the fluorescent NF array
generated by photobleaching. The arrows and arrow-
heads identify the leading and trailing end, respec-
tively, of a moving NF. The front of this fluorescent NF
enters the photobleached gap early in the sequence,
and can be seen at 15 s. It continues moving into the
gap over the next 15 s, pauses for a while, and then
moves out of the gap. Only the trailing end of this NF
can be seen at 60 and 75 s. A second, shorter NF
enters at 90 s (arrowhead with asterisk) and moves
steadily through the gap over the next 20–25 s. (F)
Histograms of the frequency of anterograde and retro-
grade NF movements in neurons treated for the indi-
cated times with control or DHC siRNA. 
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are not completely depleted of the protein. Another possibility is
that a minus-end directed kinesin such as CHO2/HSET contrib-
utes to the anterograde transport of MTs, and this would presum-
ably be the result of MTs pushing against one another rather than
actin filaments (Sharp et al., 1997). In terms of the retrograde
movements, the present data provide almost no evidence that cy-
toplasmic dynein plays a role. It seems reasonable to surmise that
a kinesin-related protein fuels the retrograde transport of MTs.
A good candidate may be Eg5, whose inhibition causes rapid
bursts in axonal growth, which would be consistent with a dimi-
nution in retrograde MT transport (Haque et al., 2004).
Ma et al. (2004) recently proposed a model in which unas-
sembled tubulin is transported in the form of an as yet unidenti-
fied organelle. Presumably such an organelle would use a kinesin
motor for anterograde and cytoplasmic dynein for retrograde
movements. Our observation that depletion of dynein diminishes
the anterograde but not the retrograde movements is inconsistent
with this model, and hence supports the contention that the mov-
ing structures are indeed short MTs (for review see Hasaka et al.,
2004). It is worth noting that unlike vesicle transport, which is
impaired in both directions after DHC depletion, the transport of
MTs or NFs is impaired in only one direction or the other. This
finding may be relevant to the differing mechanisms by which
polymer transport and vesicle transport are regulated.
Cytoplasmic dynein has a variety of other roles to play,
such as the retrograde transport of growth factors to the nu-
cleus (Heerssen et al., 2004) that could affect the expression
of myriad genes, including other motor proteins. Thus, it will
be necessary to follow up our results with more acute meth-
ods for inhibiting dynein functions and with analyses on the
broader effects of suppressing dynein expression on the neu-
ron. Even so, the fact that we obtained such different results
on MT and NF transport (and such predictable results on
Golgi distribution and vesicle transport) provides confidence
Figure 4. Anterograde MT transport is sup-
pressed  in DHC-depleted neurons. (A) Time-
lapse images reveal a MT moving in the antero-
grade  direction through the photobleached
region. Red arrows mark the leading and trail-
ing ends of the MT. (B) The frequencies
(events/min) of anterograde MT transport
were significantly decreased in DHC siRNA-
treated axons (x
2, *, P   0.05) both at 4 and
7 d after siRNA transfection. However, fre-
quencies of retrograde movements were not
significantly affected. (C) Histogram showing
that there is no significant difference between
control and DHC-depleted neurons with re-
gard to lengths of the moving MTs. (D and E)
Histograms depict mean velocity distributions
of MT movements. (F and G) Histograms depict
instantaneous velocity distributions of randomly
chosen MTs from the population depicted in D
and E, respectively. See Results and discussion
and Table S3 for details. Bar, 5  m. 
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that our results are specific and not due to a global deficit in
neuronal health or viability.
The question arises as to the substrate against which the
MTs are transported. We recently reported that pharmacologi-
cal depletion of actin filaments has very similar effects as those
obtained here with depletion of dynein, namely a reduction in
the frequency of anterograde but not retrograde MT move-
ments (Hasaka et al., 2004). These results suggest that there
may be one category of anterograde MT transport that is both
dynein and actin dependent and another category that depends
on neither. It is particularly interesting that the axon still grows
and the MT array still advances when dynein or actin is de-
pleted, suggesting that the latter category of MT transport may
be sufficient to advance the MT array as the axon grows. We
suspect that the dynein-driven transport of MTs against actin
filaments has unique functions during axonal growth, perhaps
to translocate MTs appropriately during guidance of axons to
target tissues. Future studies will be aimed at testing this hy-
pothesis, with the goal of assigning particular functions to par-
ticular categories of MT transport in the axon.
 
Materials and methods
 
Cell culture and transfection
 
Sympathetic neuronal cultures were prepared and transfected using a
nucleofection device (Amaxa) as previously described (Hasaka et al.,
2004). The EGFP-NFH and EGFP-NFM were obtained and used as previ-
ously described (Roy et al., 2000; Wang and Brown, 2002). The EGFP-
tubulin construct was purchased from CLONTECH Laboratories, Inc. Four
different siRNA duplexes were designed against different regions of the
DHC sequence using Dharmacon’s custom SMARTpool siRNA service (rat
cytoplasmic DHC1; GenBank/EMBL/DDBJ accession no. NM_019226):
5
 
 
 
-gggaggaggttatgtttaa-3
 
 
 
, 5
 
 
 
-ggtgacagctttcgaatga-3
 
 
 
, 5
 
 
 
-ccaaatacctacat-
tactt-3
 
 
 
, and 5
 
 
 
-gctcaaacatgacagaatt-3
 
 
 
. The nonspecific duplex III (Dhar-
macon) was used as control. siRNA was dissolved to 200 
 
 
 
M, aliquoted,
and stored at 
 
 
 
20
 
 
 
C. siRNA concentration at transfection was 18 
 
 
 
M.
 
Immunological techniques
 
Cultures were fixed in 
 
 
 
20
 
 
 
C methanol. Labeling used a polyclonal DHC
(R-325) antibody (1:200; Santa Cruz Biotechnology, Inc.) and a monoclo-
nal Golgi-58k antibody (1:500; Sigma-Aldrich). Secondary antibodies
were obtained from Molecular Probes and Jackson ImmunoResearch Labo-
ratories (1:200). Images were acquired using equipment previously de-
scribed (Hasaka et al., 2004) with either a Plan Apochromat 40
 
 
 
/1.00
oil objective or a Fluor 100
 
 
 
/1.30 oil objective. Fluorescence intensity
and surface area were calculated using the “outline” tool within the “mea-
surement” function of Axiovision 4.0.
 
Western blot analysis
 
Cultured neuronal lysate was precipitated with cold methanol, dissolved in
sample buffer, resolved in 5% SDS PAGE gels, and transferred onto nitro-
cellulose membranes (1,000 mA; 3 h at 4
 
 
 
C). Transfers were probed for
DHC (R-325 antibody at 1:75; secondary HRP at 1:400; Pierce Chemical
Co.) and stripped and reprobed for MAP1b as described in Slaughter and
Black (2003). Antibody chemiluminescence detection used ECL reagents
(Pierce Chemical Co.).
 
Vesicle transport assay
 
Rhodamine-dextran (MW 
 
 
 
10,000; Sigma-Aldrich) was added into cul-
ture medium at 1 mg/ml the night before imaging. 15 min before imaging,
cultures were rinsed and replaced with L15 medium supplemented with 5%
FCS and oxyrase (1:100; Oxyrase Inc.). Cultures were then sealed with
glass coverslips. Image acquisition used the system and methods described
previously (Roy et al., 2000). A total of 300 time-lapse images were taken
at 200-ms exposure and 400-ms intervals for each axon. Each dish was im-
aged for no longer than 80 min. 200 sequence frames were analyzed us-
ing IP Lab under blinded conditions. Processive movement was defined as
movement without reversal of direction or pausing 
 
 
 
25 frames.
 
NF transport assay
 
Sympathetic neurons cultured in N2 medium (
 
 
 
4 neurons/mm
 
2
 
) were
treated with laminin (1:400) 24 h after transfection. The EGFP-NFM plas-
mid was used for imaging on days 2, 3, and 4. Longer treatments used
adenovirus carrying EGFP-NFH as described in Roy et al. (2000) and
Francis et al. (2005), with the following modifications. Infection was per-
formed on day 2, laminin added on day 3, and images taken on days
5–8. NF transport imaging was performed as described in Roy et al.
(2000) and Francis et al. (2005).
 
MT transport assay
 
Sympathetic neurons were cotransfected with a tubulin-EGFP plasmid and
either DHC siRNA or control siRNA. Cells were cultured for either 4 or 7 d
before imaging. EGFP-tubulin–expressing neurons were assayed and ana-
lyzed for MT transport as described previously (Hasaka et al., 2004) with
either a 900- or 1,200-ms exposure. Recording time ranged from 11 to
15 min (242 to 301 image cycles).
Statistical analyses were performed in Microsoft Excel using P 
 
 
 
0.05 as the standard for significant difference.
 
Online supplemental material
 
Tables S1, S2, and S3 show data from the vesicle transport assay, the NF
transport assay, and the MT transport assay, respectively. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/
jcb.200407191/DC1.
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